z-logo
open-access-imgOpen Access
The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States
Author(s) -
Colleen S. Kraft,
Angela Hewlett,
Scott A. Koepsell,
Anne Winkler,
Christopher J. Kratochvil,
LuAnn Larson,
Jay B. Varkey,
Aneesh K. Mehta,
G. Marshall Lyon,
Rachel FriedmanMoraco,
Vincent C. Marconi,
Charles E. Hill,
James N. Sullivan,
Daniel W. Johnson,
Steven J. Lisco,
Mark J. Mulligan,
Timothy M. Uyeki,
Anita K. McElroy,
Tara K. Sealy,
Shelley Campbell,
Christina F. Spiropoulou,
Ute Ströher,
Ian Crozier,
Richard Sacra,
Michael Connor,
Viranuj Sueblinvong,
Harold A. Franch,
Philip W. Smith,
Bruce S. Ribner
Publication year - 2015
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/civ334
Subject(s) - medicine , ebola virus , convalescent plasma , outbreak , disease , intensive care medicine , clinical trial , covid-19 , emergency medicine , virology , infectious disease (medical specialty)
The current West Africa Ebola virus disease (EVD) outbreak has resulted in multiple individuals being medically evacuated to other countries for clinical management.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom